Navigation Links
Coalition for a Competitive Pharmaceutical Market Launches New Print Ad Campaign Highlighting Need for Meaningful Biogenerics Legislation
Date:2/14/2008

'Countless Patients Cannot Afford Life-Saving Biopharmaceuticals'

WASHINGTON, Feb. 14 /PRNewswire-USNewswire/ -- As part of its campaign to enact meaningful biogenerics legislation that would create a pathway for FDA approval of safe and effective biogenerics, CCPM unveiled a new print advertisement that features a footprint in the snow stating: "Don't Leave Patients Out in the Cold."

The ad highlights how meaningful biogenerics legislation should be balanced to foster innovation without excessive and unprecedented market exclusivity that simply extends brand monopolies. Such legislation would be an empty promise for patients.

In addition, CCPM released letters to the Administration and to the House Energy & Commerce Committee Leadership stressing the need for biologics legislation that provides a meaningful FDA pathway and not a pathway in name only.

CCPM supports public policies that facilitate timely access to affordable pharmaceuticals. Visit http://www.competitiverx.com for more information and a list of CCPM members.

Contact: Katie Braden Huffard, 202-255-5216;

Andrea Hofelich, 703-647-2495; Charles Cote, 202-207-3605


'/>"/>
SOURCE CCPM
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
2. Agendia Joins the Personalized Medicine Coalition (PMC)
3. New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
4. Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
5. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
6. Anadys Pharmaceuticals to Report Fourth Quarter and Year-End 2007 Financial Results
7. Technology Transforms Market Research in Pharmaceutical Industry
8. Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results Teleconference and Webcast
9. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
10. Vion Pharmaceuticals Holds Special Meeting of Stockholders
11. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... AMRI, a global contract research, development and ... outcomes and quality of life, will now be offering its impurity solutions as ... regulatory requirements for all new drug products, including the finalization of ICH M7 ...
(Date:10/11/2017)... ... , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. The ... Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, industry ... officials from around the world to address key issues in device compliance, quality and ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... maternal age to IVF success. , After comparing the results from the fresh ...
(Date:10/10/2017)... ... 2017 , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on ... DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of ...
Breaking Biology Technology:
(Date:8/15/2017)...   ivWatch LLC , a medical device company focused on ... receipt of its ISO 13485 Certification, the global standard for medical ... Standardization (ISO®). ... Continuous Monitoring device for the early detection of IV infiltrations. ... "This is an important milestone for ivWatch, as ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
Breaking Biology News(10 mins):